EBR Stock Overview
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
EBR Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$1.03 |
| 52 Week High | AU$1.34 |
| 52 Week Low | AU$0.53 |
| Beta | 0.75 |
| 1 Month Change | 10.75% |
| 3 Month Change | 27.16% |
| 1 Year Change | 28.75% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -0.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| EBR | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 12.6% | 3.5% | 3.1% |
| 1Y | 28.7% | 19.4% | 8.1% |
Return vs Industry: EBR exceeded the Australian Medical Equipment industry which returned 19.4% over the past year.
Return vs Market: EBR exceeded the Australian Market which returned 8.1% over the past year.
Price Volatility
| EBR volatility | |
|---|---|
| EBR Average Weekly Movement | 8.3% |
| Medical Equipment Industry Average Movement | 10.1% |
| Market Average Movement | 9.0% |
| 10% most volatile stocks in AU Market | 17.5% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: EBR's share price has been volatile over the past 3 months.
Volatility Over Time: EBR's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | n/a | John McCutcheon | ebrsystemsinc.com |
EBR Systems, Inc. develops implantable systems for wireless tissue stimulation. The company offers WiSE cardiac resynchronization therapy system that uses a proprietary wireless technology to deliver pacing stimulation directly to the inside of the left ventricle of the heart. Its products are used to eliminate lead complications, such as placement difficulty, unintended nerve stimulation, dislodgement, extraction, and repositioning.
EBR Systems, Inc. Fundamentals Summary
| EBR fundamental statistics | |
|---|---|
| Market cap | AU$317.33m |
| Earnings (TTM) | -AU$53.26m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-5.8x
P/E RatioIs EBR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EBR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$35.04m |
| Earnings | -US$35.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 127.7% |
How did EBR perform over the long term?
See historical performance and comparison